US to end almost all research using chimpanzees

Chimpanzee research in the United States may be nearly over. On June 12, the U.S. Fish and Wildlife Service (FWS) announced that it is categorizing captive chimpanzees as an endangered species subject to legal protections.

The new rule will bar most invasive research on chimpanzees. Exceptions will be granted for work that would “benefit the species in the wild” or aid the chimpanzee’s propagation or survival, including work to improve chimp habitat and the management of wild populations.

The FWS proposed the rule in 2013 to close a loophole that exempted captive chimps from the Endangered Species Act protections that had already been given to their wild counterparts. Under the law, it is illegal to import or export an endangered animal, or to “harm, harass, kill [or] injure” one.

The government’s decision to list captive chimps as endangered drew swift criticism from some science groups. “Practically speaking, [given] the process to get exceptions [for invasive research], I don’t expect chimps will be a viable option,” says Matt Bailey, executive vice president of the National Association for Biomedical Research in Washington, D.C.

Bailey’s group argues that medical research with chimpanzees benefits both humans and chimps, given that the two species are affected by many of the same diseases, and notes that captive research chimps have been bred for that purpose — making the connection to wild populations tenuous.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: U.S. government give research chimps endangered-species protection

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-06-at-11.13.59-AM
RFK Jr.’s plan to curb America’s appetite for ultra-processed foods and artificial dyes blocked by the White House
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Screenshot 2026-10-08 at 1.34
Hooked on kratom: The unregulated, natural, alcohol-free “social tonic” that is destroying lives 
Screenshot-2026-10-06-at-2.36.47-PM
Is organic farming really more sustainable? 100 recent studies say ‘no’
Screenshot-2026-09-28-at-11.26.17-AM
Viewpoint: Wellness movement activists reposition nicotine from a killer addictive drug into a cure-all for brain ills
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
Resolute-Portrait-with-Injured-Teddy-Bear
Anti-vax Texas Senate candidate Ken Paxton alleges conspiracy by doctors, drugmakers, and insurers to push childhood vaccination for profit
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
ChatGPT-Image-Sep-21-2026-11_21_39-AM
Viewpoint: Food cults: Online ‘nutrition communities’ can pose unique dangers
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
No-Data-Center-Farm-Protest-Sign-2
Rural revival or corporate windfall? Trump’s One Big Beautiful Bill tax law opens the door to big breaks for data centers—but tech giants aren’t cashing in
Supreme-Court-Amid-Climate-Crisis
Should fossil fuel companies be shielded from lawsuits over climate change damage? The Supreme Court takes up the question
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.